Some British experts have slammed the US decision to snap up nearly the entire global supply of remdesivir, the only drug licensed so far to treat COVID-19.
Ohid Yaqub, a senior lecturer at the University of Sussex called it “disappointing news” in a statement.
“It so clearly signals an unwillingness to cooperate with other countries and the chilling effect this has on international agreements about intellectual property rights,” Yaqub said.